SU‐E‐T‐199: Comparison Between Acuros XB and AAA in Homogeneous Phantoms for Volumetric Modulated Arc Therapy Plans

Purpose: To investigate the differences among Acuros XB (AXB) with dose‐to‐water report mode (AXBw), AXB with dose‐to‐medium report mode (AXBm) and Anisotropic Analytical Algorithm (AAA), in homogeneous phantoms and for volumetric modulated arc therapy (VMAT) plans. Methods: Nineteen clinically applied VMAT plans were transplanted to a Delta4 phantom and an I'mRT phantom to generate phantom plans, respectively. Each plan was calculated using AXBw, AXBm and AAA, respectively, utilizing the distributed calculation framework (DCF), and the calculation times were recorded. Each plan was delivered by the TrueBeam linear accelerator and measured using the Delta4 phantom and ionization chamber, respectively. The 3D gamma pass rates and point dose deviations were compared among AXBw, AXBm and AAA. Results: In terms of the gamma pass rates with both the criteria of 3 mm/3% (3 mm distance‐to‐agreement, 3% dose difference) and 2 mm/2%, AXBm demonstrated the significantly worst results, and no significant difference was found between AXBw and AAA. In terms of the point dose, AXBw was slightly closer to the measured dose compared with AAA, and AXBm demonstrated the maximum dose deviation from the measured dose. Moreover, AXB calculation consumed comparable time when the DCF was not busy, and consumed significantly less time when the DCF was busy. Conclusion: In the homogeneous phantoms and for the VMAT plans, AXBw has the best dose accuracy, and AAA is comparable to or slightly worse than AXBw, wheras AXBm has the worst dose accuracy. Furthermore, AXB has higher calculation efficiency than AAA.